Beni Rovinski

Vascular Pharmaceuticals announces $9M expansion of Series A financing

The mission to move forward with addressing complications for diabetic patients, specifically diabetic nephropathy that leads to kidney disease, continues Tuesday with an increase in Series A funding (a $9 million addition that brings the total to $25 million) for the clinical-stage pharmaceutical company Vascular Pharmaceuticals, Inc. (VPI). According to a press release, existing investors […]